Skip to content

Ticagrelor Related Compound 46

Ticagrelor Related Compound 46

Product Description
CAT No.
ALN-T023053
CAS No.
NA
Mol. F.
C28H42ClN9O8S2
Mol. Wt.
732.3
Stock
Please Inquire
RFQ
Chemical Name : (1S,2S,3S,5S)-3-((6-chloro-5-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Smiles : O[C@@H]1[C@@H](OCCO)C[C@@H](N2C(N=C(SCCC)N=C3NC4=C(N[C@H]5C[C@H](OCCO)[C@@H](O)[C@H]5O)N=C(SCCC)N=C4Cl)=C3N=N2)[C@@H]1O
Inchi : InChI=1S/C14H22N6O4S/c1-2-5-25-14-16-12(15)9-13(17-14)20(19-18-9)7-6-8(24-4-3-21)11(23)10(7)22/h7-8,10-11,21-23H,2-6H2,1H3,(H2,15,16,17)/t7-,8+,10+,11-/m1/s1

Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method

By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.

Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies

By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724

Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)

By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42

Request For Quotation

Related Products